Granted Patent B2

US 12,584,112 · App. 16/462,313 · Granted Mar 24, 2026

Inventors: Matthias Lutolf (Tolochenaz, CH); Nikolche Gjorevski (Renens, CH); Mike Nikolaev (Lausanne, CH); Sara Geraldo (Bussigny, CH); Nathalie Brandenberg (Lausanne, CH); Yoji Tabata (Cessy, FR)

Assignee: Ecolepol Ytechnique Federale de Lausanne

C12N5/068C12N2501/11C12N2501/155C12N2501/415C12N2506/23C12N2513/00C12N2533/54C12N2533/90C12N2535/10

Abstract

Claims (23)

1 . An in vitro method for obtaining an organoid having a pre-determined tissue shape and pattern, comprising:

i. seeding stem cells capable of differentiating to form the organoid in a three-dimensional (3D) structure within a macroscopic block of hydrogel, wherein said stem cells are isolated epithelial stem cells, and the 3D structure is a cavity within the macroscopic block of hydrogel,

wherein the cavity forms a tube comprising two open ends that allow perfusion with liquid, and,

wherein the tube comprises a longitudinal section along the longitudinal axis of the tube, wherein the section has a rectangular cross section, wherein the rectangle has sides that are between 10 μm and 5 mm in length, or the section has a circular or elliptical cross-section, wherein the ellipse has two principal axes between 10 μm and 5 mm in length,

ii. culturing the stem cells under self-renewal conditions, wherein the stem cells proliferate and pattern to form a colony having the same 3D structure as the macroscopic block of hydrogel and cover the 3D structure in the macroscopic block of hydrogel, and

iii. culturing the 3D structure of step (ii) covered with the colony of the stem cells in the presence of differentiation conditions such that the colony of the stem cells undergoes morphogenesis to form the organoid with reproducible and predictable shape and pattern,

wherein the macroscopic block of hydrogel has a minimum elastic modulus of at least 450 Pa.

2 . The method of claim 1 , wherein the epithelial stem cells are small intestinal, stomach, colon, pancreatic, lung, prostate, mammary, corneal, hair follicle, epidermal cells or progenitors of such cells.

3 . A method according to claim 1 , wherein the 3D structure is obtained by replica moulding, soft embossing, injection moulding, 3D printing, bioprinting, laser machining, micromachining, surface etching, optical lithography, additive manufacturing, electrochemical directed crosslinking soft-lithography, and/or polydimethyl siloxane (PDMS) replica moulding.

4 . The method of claim 1 , wherein a hydrogel of the macroscopic block of hydrogel comprises:

i. naturally derived components, selected from the group comprising polysaccharides, gelatinous proteins, agarose, alginate, chitosan, dextran, gelatin, laminins, collagens, hyaluronan, fibrin, or mixtures thereof, or are selected from the group of complex tissue-derived matrices consisting of Matrigel, Myogel and Cartigel, wherein the concentration of collagen in the hydrogel is between 0.4 mg/ml and about 3.6 mg/ml and Matrigel is at a percentage between 90% (v/v) and 10% (v/v); or

ii. a crosslinked synthetic hydrophilic polymer functionalized with an extracellular matrix (ECM)-derived protein or peptide, wherein the hydrophilic polymer is selected from the group comprising: poly(ethylene glycol), polyoxazoline, polyaliphatic polyurethanes, polyether polyurethanes, polyester polyurethanes, polyethylene copolymers, polyamides, polyvinyl alcohols, poly(ethylene oxide), polypropylene oxide, polypropylene glycol, polytetramethylene oxide, polyvinyl pyrrolidone, polyacrylamide, poly(hydroxy ethyl acrylate), poly(hydroxyethyl methacrylate) and mixtures or co-polymers thereof; or

iii. a combination of naturally delivered and synthetic precursors;

wherein supportive cells are cultured inside the hydrogel, the supportive cells are selected from the group comprising fibroblasts, myoblasts, myofibroblasts, endothelial cells and/or cells of the immune system.

5 . The method of claim 1 , wherein the stem cells form a tissue-like colony, the tissue-like colony comprises an epithelial-like tissue.

6 . An organoid produced by the method of claim 1 .

7 . An array of the organoids of claim 6 within a 2D plane, preferably wherein:

i. the organoids are equally spaced within the array, preferably wherein the space between adjacent organoids in the array is equal to or greater than the length of any of the adjacent organoids within the plane of the array,

ii. the size of the array is between 10 μm to 100 mm in width and/or length, and

iii. the array is folded to form a 3D shape, preferably a tube.

8 . The method of claim 1 , wherein one principal axis is longer than the other principal axis.

9 . The method of claim 5 , wherein the epithelial-like tissue comprises a lumenized multicellular structure.

10 . The method of claim 5 , wherein the tissue-like colony comprises an accessible epithelium.

Assignments (1)

Priority Claims (1)

Continuity (1)

References Cited (28)